Design and synthesis of a biaryl series as inhibitors for the bromodomains of CBP/P300
作者:Kwong Wah Lai、F. Anthony Romero、Vickie Tsui、Maureen H. Beresini、Gladys de Leon Boenig、Sarah M. Bronner、Kevin Chen、Zhongguo Chen、Edna F. Choo、Terry D. Crawford、Patrick Cyr、Susan Kaufman、Yingjie Li、Jiangpeng Liao、Wenfeng Liu、Justin Ly、Jeremy Murray、Weichao Shen、John Wai、Fei Wang、Caicai Zhu、Xiaoyu Zhu、Steven Magnuson
DOI:10.1016/j.bmcl.2017.11.025
日期:2018.1
A novel, potent, and orally bioavailable inhibitor of the bromodomain of CBP, compound 35 (GNE-207), has been identified through SAR investigations focused on optimizing al bicyclic heteroarene to replace the aniline present in the published GNE-272 series. Compound 35 has excellent CBP potency (CBP IC50 = 1 nM, MYC EC50 = 18 nM), a selectively index of >2500-fold against BRD4(1), and exhibits a good